Currently out of the existing stock ratings of Justin Smith, 12 are a BUY (80%), 2 are a HOLD (13.33%), 1 are a SELL (6.67%).

Justin Smith

Work Performance Price Targets & Ratings Chart

Analyst Justin Smith, currently employed at SOCGEN, carries an average stock price target met ratio of 67.86% that have a potential upside of 27.17% achieved within 278 days.

Justin Smith’s has documented 40 price targets and ratings displayed on 10 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 11-Mar-2024.

Wall Street Analyst Justin Smith

Analyst best performing recommendations are on SE (SEA LTD).
The best stock recommendation documented was for SE (SEA LTD) at 1/9/2023. The price target of $60 was fulfilled within 4 days with a profit of $6.96 (13.12%) receiving and performance score of 32.81.

Average potential price target upside

of $20.12 (52.69%) on BMY (BRISTOL-MYERS SQUIBB COMPANY).
of $8.52 (21.89%) on GSK (GLAXOSMITHKLINE PLC ADR).

BMY Bristol-Myers Squibb Company GSK GlaxoSmithKline PLC ADR AZN AstraZeneca PLC ADR ABBV AbbVie SE Sea Ltd FMS Fresenius Medical Care GMAB Genmab AS FSNUY Fresenius SE KGaA ADR RHHBY Roche Holding Ltd ADR MRK Merck mpany

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Mohit Bansal (WELLS FARGO)